Home
Caplin Point Laboratories Ltd Share Price History
Caplin Point Laboratories Ltd
NSE : 21 Feb, 2025
2029.85-19.8 (-1.0%)
Prev Close
2049.6
Open Price
2049.6
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
63836
Today's High / Low
2099.7 / 2023.1
52 WK High / Low
2641.0 / 1225.0
Market Price of Caplin Point Laboratories Ltd
1M
1Y
3Y
5Y
Monitoring Caplin Point Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 12.64 |
| YoY Gr. | - |
| Net Profit (Cr.) | 96 |
| BVPS | 29.74 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 68.71 |
| Op. Profit Mgn % | 24.92 |
| Net Profit Mgn % | 16.34 |
| Debt to Equity % | 0.04 |
Latest Shareholding
Promoters Holdings Over Time
About Caplin Point Laboratories Ltd
- Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990.
- The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
- Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
- It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
- In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.
Popular Search
FAQs for Caplin Point Laboratories Ltd Share Price History
What are the key events that typically impact Caplin Point Laboratories Ltd's share price history?
Key events that impact Caplin Point Laboratories Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Caplin Point Laboratories Ltd's share price history?
Stock splits reduce the nominal price of Caplin Point Laboratories Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Caplin Point Laboratories Ltd?
Dividends can influence Caplin Point Laboratories Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Caplin Point Laboratories Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Caplin Point Laboratories Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Caplin Point Laboratories Ltd’s share price history?
To understand Caplin Point Laboratories Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
